Catalyst Wire Dossier Catalyst Wire Dossier

PR022 topical gel

· Realm Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PR022 topical gel, covering 2017-12-21 to 2017-12-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis [Phase 2]

See pricing